Association of a F479L variant in the cytosolic phospholipase A2 gene (PLA2G4A) with decreased glucose turnover and oxidation rates in Pima Indians

被引:13
作者
Wolford, JK [1 ]
Konheim, YL [1 ]
Colligan, PB [1 ]
Bogardus, C [1 ]
机构
[1] NIDDKD, Clin Diabet & Nutr Sect, Phoenix Epidemiol & Res Branch, NIH, Phoenix, AZ 85016 USA
关键词
chromosome; 1q; single nucleotide polymorphisms (SNPs); candidate gene analysis; glucose oxidation; lipid oxidation; type 2 diabetes mellitus; arachidonic acid;
D O I
10.1016/S1096-7192(03)00051-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Phospholipase A2, Group IVA (PLA2G4A) belongs to the class of cytosolic calcium-dependent phospholipases (cPLA2s) that preferentially cleave arachidonic acid (AA) from membrane glycerophospholipids. AA and AA metabolites play key roles in glucose disposal and insulin secretion. PLA2G4A is located on Chromosome 1q, where a number of groups have reported linkage to type 2 diabetes mellitus. We have screened the PLA2G4A gene and identified a C --> G variant, which predicts a phenylalanine to leucine substitution. In logistic regression analyses adjusted for age, sex, ethnicity, and birth year, we found a trend toward association between this SNP and diabetes [OR= 1.53 (0.97-2.40); p = 0.06]. Individuals with the variant genotype had lower mean basal endogenous glucose output (1.8 +/- 0.03 vs. 1.9 +/- 0.01 mg/kgEMBS/min,- p = 0.04) and lower mean basal glucose oxidation (1.2 +/- 0.11 vs. 1.4 +/- 0.03 mg/kgEMBS/min; p = 0.005) compared to individuals with the wild-type genotype. During a low dose insulin infusion, non-diabetic individuals with the variant genotype had a lower mean glucose oxidation (1.9 0.11 vs. 2.0 +/- 0.03 mg/kgEMBS/min; p = 0.04) and total glucose turnover rate (2.5 +/- 0.22 vs. 2.6 +/- 0.06 mg/kg EMBS/min; p = 0.01) compared to subjects with the wild-type genotype. In addition, under basal conditions, individuals with the variant genotype had a higher mean lipid oxidation rate compared to individuals with the wild-type genotype (0.77 +/- 0.25 vs. 0.67 +/- 0.23 mg/ kgEMBS/min; p = 0.02). These results provide evidence supporting a role for the eicosanoid biosynthesis pathway in type 2 diabetes mellitus pathophysiology. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 43 条
[1]   Augmented insulinotropic action of arachidonic acid through the lipoxygenase pathway in the obese Zucker rat [J].
Ahrén, B ;
Magrum, LJ ;
Havel, PJ ;
Greene, SF ;
Phinney, SD ;
Johnson, PR ;
Stern, JS .
OBESITY RESEARCH, 2000, 8 (06) :475-480
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]   PPARγ, the ultimate thrifty gene [J].
Auwerx, J .
DIABETOLOGIA, 1999, 42 (09) :1033-1049
[5]   FAMILIAL DEPENDENCE OF THE RESTING METABOLIC-RATE [J].
BOGARDUS, C ;
LILLIOJA, S ;
RAVUSSIN, E ;
ABBOTT, W ;
ZAWADZKI, JK ;
YOUNG, A ;
KNOWLER, WC ;
JACOBOWITZ, R ;
MOLL, PP .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (02) :96-100
[6]   Identification of calcium-dependent phospholipase A2 isoforms in human and rat pancreatic islets and insulin secreting beta-cell lines [J].
Chen, M ;
Yang, ZD ;
Naji, A ;
Wolf, BA .
ENDOCRINOLOGY, 1996, 137 (07) :2901-2909
[7]   A NOVEL ARACHIDONIC ACID-SELECTIVE CYTOSOLIC PLA2 CONTAINS A CA2+-DEPENDENT TRANSLOCATION DOMAIN WITH HOMOLOGY TO PKC AND GAP [J].
CLARK, JD ;
LIN, LL ;
KRIZ, RW ;
RAMESHA, CS ;
SULTZMAN, LA ;
LIN, AY ;
MILONA, N ;
KNOPF, JL .
CELL, 1991, 65 (06) :1043-1051
[8]   Thiazolidinediones: a new class of antidiabetic drugs [J].
Day, C .
DIABETIC MEDICINE, 1999, 16 (03) :179-192
[9]   THE TRIUMVIRATE - BETA-CELL, MUSCLE, LIVER - A COLLUSION RESPONSIBLE FOR NIDDM [J].
DEFRONZO, RA .
DIABETES, 1988, 37 (06) :667-687
[10]   A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians [J].
Elbein, SC ;
Hoffman, MD ;
Teng, K ;
Leppert, MF ;
Hasstedt, SJ .
DIABETES, 1999, 48 (05) :1175-1182